-
Healthcare Resource Utilization and Economic Burden of Metastatic Pancreatic Cancer: A US Commercial and Medicare Claims Analysis From 2020 to 2023
Mar 10, 2025, 14:00 PM -
The Importance of Medicare Advantage Plan Design and Impact on Health Equity
Mar 10, 2025, 14:00 PM -
The Association Between COVID-19 Vaccination History and the Incidence of COVID-19 and Healthcare Resource Use in Rural Residents in Japan
Mar 10, 2025, 14:00 PM -
Bridging the Gap between the NAPOLI 3 Trial and Real-World Practice: Real-World Overall Survival (OS) of First-Line (1L) FOLFIRINOX in Metastatic Pancreatic Ductal Adenocarcinoma (mPDAC)
Mar 10, 2025, 14:00 PM -
Evolving HTA and Potential EU HTAR Ripple Effects in the US: Insights From a Stakeholder Survey
Mar 10, 2025, 14:00 PM -
Psychometric Evidence Supporting the Use of the EQ-5D in Long COVID: A Systematic Review
Mar 10, 2025, 14:00 PM -
Costs of Initiated Potentially Inappropriate Medication in 2021-2022 in Quebec, Canada
Mar 10, 2025, 14:00 PM -
Variables Statistically Associated With Mental Health Among United States Adults With Asthma in the Medical Expenditure Panel Survey
Mar 10, 2025, 14:00 PM -
Qualitative Assessment of the Idiopathic Hypersomnia Severity Scale: Suitability for Use As a Clinical Trial Endpoint as Demonstrated in NCT05156047
Mar 10, 2025, 14:00 PM -
A Systematic Literature Review on Symptom Burden and Impact of Disease on Quality of Life in Patients With Essential Thrombocythemia
Mar 10, 2025, 14:00 PM -
Estimating the Cost at which GLP-1 RAs Would become Cost-Effective for Multimorbid Type 2 Diabetes Patients in Canada
Mar 10, 2025, 14:00 PM -
Cost-Effectiveness of Pembrolizumab as Treatment for FIGO 2014 Stage III-IVA Cervical Cancer in the United States
Mar 10, 2025, 14:00 PM -
Evaluating the Impact of Luxturna Gene Therapy on Vision Improvement and Disease Progression in Patients With RPE65 Mutation-Associated Inherited Vision Loss
Mar 10, 2025, 14:00 PM -
An Evaluation of PhlexNeuron, an Internal, Proprietary Artificial Intelligence (AI) Tool for Systematic Literature Review (SLR) Screening
Mar 10, 2025, 14:00 PM -
Colorectal Cancer Screening Initiation Among Newly Age-Eligible Medicaid-Insured Individuals in Texas
Mar 10, 2025, 14:00 PM -
GenAI for Critical Appraisal of Evidence for Systematic Literature Reviews (SLRs): A Face-Off between GenAI and Human Reviewers
Mar 10, 2025, 14:00 PM -
Assessing the Added Value of Fixed-Dose Combinations in Non-Communicable Diseases: A Comparative HTA Analysis Across Canada, Scotland, France, and Germany (2014-2024)
Mar 10, 2025, 14:00 PM -
The Burden of Migraine in Brazil's Private Healthcare System: Results From the Brazil Migraine Real-World Evidence (BREM) Study
Mar 10, 2025, 14:00 PM -
Trends in Antidiabetic Medication Use and Outpatient Pharmacy Costs in a Commercially Insured Diabetes Population from a US Payer Perspective
Mar 10, 2025, 14:00 PM -
Unmet Need in Non-Metastatic Oral Cavity Cancer in the United States: A Targeted Literature Review
Mar 10, 2025, 14:00 PM
